|
US6355255B1
(en)
*
|
1998-12-07 |
2002-03-12 |
Regents Of The University Of Minnesota |
Streptococcal C5a peptidase vaccine
|
|
US5846547A
(en)
*
|
1996-01-22 |
1998-12-08 |
Regents Of The University Of Minnesota |
Streptococcal C5a peptidase vaccine
|
|
US6676943B1
(en)
|
1997-04-24 |
2004-01-13 |
Regents Of The University Of Minnesota |
Human complement C3-degrading protein from Streptococcus pneumoniae
|
|
EP1051483A1
(en)
*
|
1997-12-31 |
2000-11-15 |
Pincus, Seth H. |
A method of isolating a peptide which immunologically mimics microbial carbohydrates including group b streptococcal carbohydrates and the use thereof
|
|
KR20010089280A
(ko)
*
|
1998-09-24 |
2001-09-29 |
리전츠 오브 더 유니버스티 오브 미네소타 |
스트렙토코쿠스 뉴모니애로부터의 인간 보체 ｃ3 분해폴리펩티드
|
|
US7256265B2
(en)
*
|
1999-12-03 |
2007-08-14 |
Regents Of The University Of Minnesota |
Streptococcal C5a peptidase vaccine
|
|
ES2330083T3
(es)
*
|
2000-10-27 |
2009-12-04 |
Novartis Vaccines And Diagnostics S.R.L. |
Acidos nucleicos y proteinas de estreptococos de los grupos a y b.
|
|
AU2004226909B2
(en)
*
|
2000-10-27 |
2008-02-07 |
J. Craig Venter Institute, Inc. |
Nucleic acids and proteins from streptococcus groups A & B
|
|
GB2370770B
(en)
*
|
2001-01-03 |
2005-06-01 |
Simon Connolly |
Uses of Streptococcus Vaccines
|
|
MX339524B
(es)
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
|
US20070053924A1
(en)
*
|
2002-08-26 |
2007-03-08 |
Herve Tettelin |
Conserved and specific streptococcal genomes
|
|
US7785608B2
(en)
*
|
2002-08-30 |
2010-08-31 |
Wyeth Holdings Corporation |
Immunogenic compositions for the prevention and treatment of meningococcal disease
|
|
US7301554B2
(en)
*
|
2002-09-20 |
2007-11-27 |
Ricoh Company, Ltd. |
Light scanning device, scanning line adjusting method, scanning line adjusting control method, image forming apparatus, and image forming method
|
|
ES2505695T3
(es)
|
2003-07-31 |
2014-10-10 |
Novartis Vaccines And Diagnostics, Inc. |
Composiciones inmunógenas para Streptococcus pyogenes
|
|
US8945589B2
(en)
*
|
2003-09-15 |
2015-02-03 |
Novartis Vaccines And Diagnostics, Srl |
Immunogenic compositions for Streptococcus agalactiae
|
|
EP2612679A1
(en)
*
|
2004-07-29 |
2013-07-10 |
Novartis Vaccines and Diagnostics, Inc. |
Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
|
|
AU2005294275B2
(en)
*
|
2004-10-08 |
2012-09-13 |
Glaxosmithkline Biologicals S.A. |
Immunogenic and therapeutic compositions for Streptococcus pyogenes
|
|
TW200806315A
(en)
|
2006-04-26 |
2008-02-01 |
Wyeth Corp |
Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
|
|
WO2009030978A2
(en)
*
|
2006-06-09 |
2009-03-12 |
Novartis Ag |
Conformers of bacterial adhesins
|
|
US7364291B2
(en)
*
|
2006-06-29 |
2008-04-29 |
Johnson & Johnson Vision Care, Inc. |
Contact lenses with light blocking rings
|
|
JP2010508276A
(ja)
*
|
2006-10-30 |
2010-03-18 |
ノバルティス アーゲー |
化膿連鎖球菌のための免疫原性組成物および治療組成物
|
|
US20080311129A1
(en)
*
|
2006-11-02 |
2008-12-18 |
Camas Incorporated |
Adherence inhibitor directed to and method of making and using
|
|
AR064642A1
(es)
|
2006-12-22 |
2009-04-15 |
Wyeth Corp |
Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
|
|
HU227970B1
(en)
|
2007-07-10 |
2012-07-30 |
Egis Gyogyszergyar Nyrt |
Pharmaceutical compositions containing silicones of high volatility
|
|
CA2699513C
(en)
|
2007-09-12 |
2018-03-13 |
Novartis Ag |
Gas57 mutant antigens and gas57 antibodies
|
|
NZ586430A
(en)
|
2007-12-21 |
2012-09-28 |
Novartis Ag |
Mutant forms of streptolysin o (slo)
|
|
NZ614064A
(en)
|
2008-11-05 |
2015-04-24 |
Wyeth Llc |
Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (bhs) disease
|
|
PL3170508T3
(pl)
|
2010-06-04 |
2020-04-30 |
Wyeth Llc |
Preparaty szczepionek
|
|
SI2608805T2
(sl)
|
2010-08-23 |
2025-09-30 |
Wyeth Llc |
Stabilne formulacije antigenov rLP2086 neisserie meningitidis
|
|
BR112013005329A2
(pt)
|
2010-09-10 |
2017-05-02 |
Wyeth Llc |
variantes não lipidadas de antígenos orf2086 de neisseria meningitidis
|
|
ITMI20111182A1
(it)
|
2011-06-28 |
2012-12-29 |
Canio Buonavoglia |
Vaccino per coronavirus canino
|
|
US9078842B2
(en)
*
|
2011-10-26 |
2015-07-14 |
Wisconsin Alumni Research Foundation |
Peptide for reducing the phosphate requirement and excretion from farm animals
|
|
SA115360586B1
(ar)
|
2012-03-09 |
2017-04-12 |
فايزر انك |
تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
|
|
MX2018011291A
(es)
|
2012-03-09 |
2023-01-31 |
Pfizer |
Composiciones de neisseria meningitidis y metodos de las mismas.
|
|
WO2014136064A2
(en)
|
2013-03-08 |
2014-09-12 |
Pfizer Inc. |
Immunogenic fusion polypeptides
|
|
BR112016004463A2
(pt)
|
2013-09-08 |
2017-10-17 |
Pfizer |
composições de neisseria meningitidis e métodos das mesmas
|
|
EP2886140A1
(en)
*
|
2013-12-17 |
2015-06-24 |
University of Limerick |
An apparatus for the extracorporeal treatment of blood
|
|
US9107906B1
(en)
|
2014-10-28 |
2015-08-18 |
Adma Biologics, Inc. |
Compositions and methods for the treatment of immunodeficiency
|
|
WO2016132294A1
(en)
|
2015-02-19 |
2016-08-25 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
US10544197B2
(en)
|
2016-08-12 |
2020-01-28 |
Wisconsin Alumni Research Foundation |
FGF-23 epitope peptide for improving resistance to breakage and eggshell strength
|
|
AU2018215585B2
(en)
|
2017-01-31 |
2022-03-17 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
US10259865B2
(en)
|
2017-03-15 |
2019-04-16 |
Adma Biologics, Inc. |
Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
|
|
MX2022003682A
(es)
|
2019-09-27 |
2022-04-25 |
Pfizer |
Composiciones de neisseria meningitidis y metodos de las mismas.
|
|
AU2021368151B2
(en)
|
2020-10-27 |
2024-09-05 |
Pfizer Inc. |
Escherichia coli compositions and methods thereof
|
|
US12357681B2
(en)
|
2020-12-23 |
2025-07-15 |
Pfizer Inc. |
E. coli FimH mutants and uses thereof
|
|
US20220387613A1
(en)
|
2021-05-28 |
2022-12-08 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
JP2024521847A
(ja)
|
2021-05-28 |
2024-06-04 |
ファイザー・インク |
コンジュゲート化莢膜糖抗原を含む免疫原性組成物およびその使用
|
|
WO2023135515A1
(en)
|
2022-01-13 |
2023-07-20 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
WO2024110827A1
(en)
|
2022-11-21 |
2024-05-30 |
Pfizer Inc. |
Methods for preparing conjugated capsular saccharide antigens and uses thereof
|
|
JP2025537898A
(ja)
|
2022-11-22 |
2025-11-20 |
ファイザー・インク |
コンジュゲートさせた莢膜糖類抗原を含む免疫原性組成物およびその使用
|
|
WO2024166008A1
(en)
|
2023-02-10 |
2024-08-15 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
AU2024246082A1
(en)
|
2023-03-30 |
2025-10-16 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
AU2024255922A1
(en)
|
2023-04-14 |
2025-10-30 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
WO2024224266A1
(en)
|
2023-04-24 |
2024-10-31 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
TW202527906A
(zh)
|
2023-09-14 |
2025-07-16 |
美商輝瑞股份有限公司 |
包含經結合之肺炎鏈球菌莢膜醣抗原之佐劑化致免疫性組成物及其用途
|
|
WO2025133971A1
(en)
|
2023-12-23 |
2025-06-26 |
Pfizer Inc. |
Improved methods for producing bacterial capsular saccharide glycoconjugates
|
|
WO2025186705A2
(en)
|
2024-03-06 |
2025-09-12 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
WO2025191415A1
(en)
|
2024-03-11 |
2025-09-18 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated escherichia coli saccharides and uses thereof
|
|
WO2025219908A2
(en)
|
2024-04-19 |
2025-10-23 |
Pfizer Inc. |
Media and fermentation methods for polysaccharide production in bacterial cell culture
|
|
WO2025219904A1
(en)
|
2024-04-19 |
2025-10-23 |
Pfizer Inc. |
Improved methods for producing glycoconjugates by reductive amination in aprotic solvent
|